Stage I and II Small-Cell Lung Cancer-New Challenge for Surgery.

Fabian DörrSebastian StangeMaximilian MichelGeorg SchlachtenbergerHruy MengheshaThorsten WahlersKhosro HekmatMatthias B Heldwein

Published in: Lung (2022)

Our meta-analysis shows a significant survival benefit after surgery not only in the recommended stage I but also in stage II SCLC. Our data suggests that both stages should be considered for surgery of early SCLC.

Keyphrases

minimally invasive
small cell lung cancer
coronary artery bypass
systematic review
surgical site infection
electronic health record
meta analyses
coronary artery disease
percutaneous coronary intervention
artificial intelligence
data analysis